key: cord-0952020-bt6fcuey
authors: Resende, Paola Cristina; Naveca, Felipe G; Lins, Roberto D; Dezordi, Filipe Zimmer; Ferraz, Matheus V. F; Moreira, Emerson G; Coêlho, Danilo F; Motta, Fernando Couto; Paixão, Anna Carolina Dias; Appolinario, Luciana; Lopes, Renata Serrano; Mendonça, Ana Carolina da Fonseca; da Rocha, Alice Sampaio Barreto; Nascimento, Valdinete; Souza, Victor; Silva, George; Nascimento, Fernanda; Neto, Lidio Gonçalves Lima; da Silva, Fabiano Vieira; Riediger, Irina; Debur, Maria do Carmo; Leite, Anderson Brandao; Mattos, Tirza; da Costa, Cristiano Fernandes; Pereira, Felicidade Mota; dos Santos, Cliomar Alves; Rovaris, Darcita Buerger; Fernandes, Sandra Bianchini; Abbud, Adriano; Sacchi, Claudio; Khouri, Ricardo; Bernardes, André Felipe Leal; Delatorre, Edson; Gräf, Tiago; Siqueira, Marilda Mendonça; Bello, Gonzalo; Wallau, Gabriel L
title: The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the spike protein
date: 2021-08-14
journal: Virus Evol
DOI: 10.1093/ve/veab069
sha: cadfaa2df9b29b01be6b926f3d6cc684fca72be7
doc_id: 952020
cord_uid: bt6fcuey

Mutations at both the receptor-binding domain (RBD) and the amino (N)-terminal domain (NTD) of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike (S) glycoprotein can alter its antigenicity and promote immune escape. We identified that SARS-CoV-2 lineages circulating in Brazil with mutations of concern in the RBD independently acquired convergent deletions and insertions in the NTD of the S protein, which altered the NTD antigenic-supersite and other predicted epitopes at this region. Importantly, we detected the community transmission of different P.1 lineages bearing NTD indels ∆69-70 (which can impact several SARS-CoV-2 diagnostic protocols), ∆144 and ins214ANRN, and a new VOI N.10 derived from the B.1.1.33 lineage carrying three NTD deletions (∆141–144, ∆211, and ∆256–258). These findings support that the ongoing widespread transmission of SARS-CoV-2 in Brazil generates new viral lineages that might be more resistant to antibody neutralization than parental variants of concern.

Recurrent deletions in the amino (N)-terminal domain (NTD) of the spike (S) glycoprotein of SARS-CoV-2 have been identified during long-term infection of immunocompromised patients (Avanzato et al. 2020; Choi et al. 2020; Kemp et al. 2021; McCarthy et al. 2021 ) as well as during extended human-to-human transmission (McCarthy et al. 2021 ). Most of those deletions (90 per cent) maintain the reading frame and cover four recurrent deletion regions (RDRs) within the NTD at positions 60-75 (RDR1), 139-146 (RDR2), 210-212 (RDR3), and 242-248 (RDR4) of the S protein (McCarthy et al. 2021) . The RDRs that occupy defined antibody epitopes within the NTD and RDR regions might alter antigenicity (McCarthy et al. 2021) . Interestingly, the RDRs overlap with four NTD Indel Regions (', Tem um ' e um espaco a mais IR-2 to that are prone to gain or lose short nucleotide sequences during sarbecoviruses evolution known to infect animals and humans (Garry et al. 2021; Holmes et al. 2021) .

Since late 2020, several more transmissible variants of concern (VOCs) and also variants of interest (VOIs) with convergent mutations at the receptor-binding domain (RBD) of the S protein (particularly E484K and N501Y) arose independently in humans (Rambaut et al. 2020; Tegally et al. 2021) . Some VOCs also displayed NTD deletions such as lineages B.1.1.7 (RDR2 ∆144), B.1.351 (RDR4 ∆242-244), and P.3 (RDR2 ∆141-143) that were initially detected in the UK, South Africa, and the Philippines, respectively (McCarthy et al. 2021 ). The VOCs B.1.1.7 and B.1.351 are resistant to neutralization by several anti-NTD monoclonal antibodies (mAbs), and NTD deletions at RDR2 and RDR4 are essential for such phenotype (Collier et al. 2021; Gobeil et al. 2021; McCallum et al. 2021: 2; Wang et al. 2021a Wang et al. : 7, 2021b . Thus, NTD mutations and deletions represent an important mechanism of immune evasion and accelerate SARS-CoV-2 adaptive evolution in humans.

Several SARS-CoV-2 variants with mutations in the RBD have been described in Brazil, including the VOC P.1 (now also known as gamma) (Faria et al. 2021 ) and the VOIs P.2 (Voloch et al. 2021) and N.9 (Resende et al. 2021 ), but none of them displayed indels in the NTD. Importantly, although the VOC P.1 displayed NTD mutations (L18F) that abrogate binding of some anti-NTD mAbs (McCallum et al. 2021: 2) and further showed reduced binding to RBD-directed antibodies, it is more susceptible to anti-NTD mAbs than other VOCs (Collier et al. 2021; Dejnirattisai et al. 2021: 2; Gobeil et al. 2021; McCallum et al. 2021: 2; Wang et al. 2021a Wang et al. : 7, 2021b . In this study, we characterized the emergence of RDR variants within the VOC P.1, the VOI P.2, and a new VOI descendant of lineage B.1.1.33 (designated as N.10) that were circulating in Brazil between November 2020 and February 2021.

The Fiocruz COVID-19 Genomic Surveillance Network identified forty-three SARS-CoV-2 sequences from seven different Brazilian states that harbor a variable combination of mutations in the RBD (K417T, E484K, and N501Y) and indels in the NTD region of the S protein and were classified within lineages P.1 (n = 21), N.10 (n = 17), and P.2 (n = 2) (Supplementary Appendix Table  A1 ). All NTD indels here detected were well-supported by several high-quality reads longer than the indels (Supplementary  Appendix Table A1 and Supplementary Fig. S1 ), indicating that such genomic variations are real and not sequencing artifacts. The most frequent deletions in lineage P.1 were ∆69-70 in the RDR1; ∆144 and ∆141-144 in the RDR2; ∆189-190 and ∆242-244 in the RDR4. We also detected four P.1 genomes bearing an ins214ANRN insertion upstream to RDR3 that were part of a complex family of P.1-related variants that share several, but not all, lineagedefining mutations of VOC P.1 (Naveca et al. 2021) . The two NTD deletions in the VOI P.2 were ∆144 and ∆141-144. Inspection of sequences available at EpiCoV database in the GISAID (https:// www.gisaid.org/) on 31 May 2021 retrieved a large number of lineage P.1 (n = 101) sequences and a more reduced number of B.1.1.28 (n = 18) or P.2 (n = 13) variants with similar NTD indels sampled in Brazil (Franceschi et al. 2021; Lamarca et al. 2021; Martins et al. 2021; Siqueira et al. 2021; Slavov et al. 2021; Tosta et al. 2021) (Table 1 ) and other countries (Supplementary Appendix Table A2 ).

The emergence of NTD indels within lineage B.1.1.33 was rare. Our genomic survey identified 17 B.1.1.33 sequences that displayed both RBD mutations and NTD deletions and that were designated as a new PANGO lineage N.10 (Table 1 ). This new VOI N.10 exhibited fourteen lineage-defining genetic changes, including ten non-synonymous mutations, three in-frame deletions, and one frame-shifting 4nt deletion (Supplementary Appendix  Table A3 ). Eight lineage-defining genetic changes were located in the S protein where two are non-synonymous mutations at the RBD (E484K and V445A), two non-synonymous mutations at the NTD (I210V and L212I), and deletions at RDR2 (∆141-144), RDR3 (∆211), and close to RDR4 (∆256-258) in the NTD. All N.10 sequences identified in our study were sampled in the Northeastern Brazilian state of Maranhão between 4 January and 1 May 2021. Inspection of sequences available at EpiCoV database retrieved seven additional N.10 sequences from the states of Maranhão (n = 3), Amapá (n = 2), and São Paulo (n = 2) sampled between 29 December 2020 and 26 April 2021 as well as only three additional B.1.1.33 Brazilian sequences carrying NTD-indels ∆141-144, ∆144, and ∆144-145 sampled between 8 March and 11 May 2021.

The Maximum Likelihood (ML) phylogenetic analysis of lineage P.1 supports the recurrent emergence of most NTD variants, except for ∆189-190 and ins214ANRN (Fig. 1A) . Among Brazilian P.1 variants with NTD deletions, 41 per cent appeared as singletons intermixed among non-deleted P.1 sequences, 47 per cent branched in three sub-clades (I-III) that also include nondeleted P.1 sequences, and 12 per cent branched in two subclades (IV and V) that only comprises sequences with NTD deletions. Sub-clade I (aLRT = 86 per cent) comprises ten sequences: six P.1+∆144 from Amazonas and Bahia states, two P.1+∆189-190, and two P.1. Sub-clade II (aLRT = 75 per cent) comprises eight sequences: three P.1+∆69-70 from São Paulo state plus one P.1+∆143-144 from Rio de Janeiro state and four P.1. Sub-clade III (aLRT = 86 per cent) comprises six sequences from São Paulo state: four P.1+∆69-70 plus two P.1. Sub-clade IV (aLRT = 79 per cent) comprises two P.1+∆144 sequences from São Paulo state, and sub-clade V (aLRT = 85 per cent) comprises two P.1+∆69-70 sequences from Santa Catarina state. This analysis also identified multiple clusters of P.1 variants with NTD deletions outside Brazil, including a large P.1+∆141-143 sub-clade in the USA (n = 61, aLRT = 99 per cent) and a small P.1+∆139-144 sub-clade in France (n = 4, aLRT = 92 per cent). The ML phylogenetic analysis of lineage B.1.1.33 confirms that all sequences belonging to VOI N.10 branched in highly supported (aLRT = 100 per cent) monophyletic clade (Fig. 1B) . 

Inspection of sequences available at EpiCoV database in the GISAID (https://www.gisaid.org/) up to 31 May 2021 revealed that frequency of SARS-CoV-2 genomes with NTD deletions ∆69-70, ∆144, ∆141-144, ∆189-190, ∆242-244, and ∆256-258 emerged in many different lineages (Supplementary Appendix  Table A4 ) and displayed a consistent increase over time worldwide, particularly from July 2020, even after removing genomes of VOCs B.1.1.7 and B.1.351 that were mostly associated with the widespread dissemination of NTD deletions ∆69-70/∆144 and ∆242-244, respectively ( Fig. 2A ). NTD insertions were much less prevalent than deletions, but their frequency also increased in 2021 (Fig. 2B ). The ins214ANRN motif was exclusive of lineage P.1, but other ins214 motifs of three to four amino acids were detected in several lineages, including the VOC B.1.1.7 (Supplementary Appendix Table A5 ). Most ins214 motifs were unique, except for the ins214AAG and ins214TDR that arose independently in several lineages, including the A.2.5 (ins214AAG) and B.1.214.2 (ins214TDR) that spread in Central/North America and Europe, respectively.

To better understand the evolutionary context of NTD indels, we aligned the S protein of representative sequences of SARS-CoV-2 lineages with NTD indels and SARS-CoV-2-related coronavirus (SC2r-CoV) lineages from bats and pangolins (Wacharapluesadee et al. 2021). Inspection of the alignment confirms that most NTD indels detected in the SARS-CoV-2 lineages occur within IR previously defined in sarbecovirus (Fig. 3) . The ∆141-144 occurs in the IR-3 located in the central part of the NTD, where some bat SC2r-CoVs also have deletions. The ∆211 and ins214 occur near the IR-4 where some bat SC2r-CoVs from China (RmYN02, ins214GATP), Thailand (RacCS203, ins214GATP), and Japan (Rc-o319, ins214GATS) displayed a four-amino-acid insertion. Although amino acid motifs at ins214 are very different across SARS-CoV-2 and SC2r-CoV lineages, the insertion size (three to four amino acids) was conserved. Deletions ∆242-244 and ∆256-258 occur immediately upstream and downstream to IR-5, respectively, where some bat and pangolin SC2r-CoV lineages also displayed deletions. Thus, NTD regions prone to gain indels during viral transmission among animals are the same as those detected during transmissions in humans.

Epitope mapping showed that neutralizing antibodies are primarily directed against the RBD and NTD of the S protein (Barnes et al. 2020; Liu et al. 2020; Piccoli et al. 2020; Voss et al. 2020; Wang et al. 2021) . Some of the RBD mutations (K417T and E484K) detected in the VOCs and VOIs circulating in Brazil have been associated with increased resistance to neutralization by mAbs or polyclonal sera from convalescent and vaccinated subjects (Baum et al. 2020; Ferraz et al. 2021; Greaney et al. 2021; Hoffmann et al. 2021; Nelson et al. 2021) . The RDR2 and RDR4 are located in the N3 (residues 141-156) and N5 (residues 246-260) loops that compose the NTD antigenic-supersite (Cerutti et al. 2021; Chi et al. 2020 : 2). Deletions at those RDRs are also an essential mechanism for SARS-CoV-2-immune evasion of anti-NTD Abs (McCallum et al. 2021; McCarthy et al. 2021; Wang et al. 2021a: 7; Wibmer et al. 2021) . To further visualize the potential impact of NTD deletions on immune recognition, we performed a modeling analysis of the binding interface between the NTD region and the NTD-directed neutralizing antibody (NAb) 2-51 derived from a convalescent donor (Liu et al. 2020; Cerutti et al. 2021 ). The NAb 2-51 interacts with the wild-type NTD antigenic-supersite (EPI_ISL_402124) through several contacts with loops N3 and N5, with a predominance of hydrophobic contacts and dispersion interactions in N5 and saline interactions in N3 ( Fig. 4A and B ). Our analyses corroborate that deletions at RDR2/IR-3 (∆144, ∆143-144, and ∆141-144) and RDR4/IR-5 (∆242-244 and ∆256-258) detected in Brazilian sequences impact the N3 and N5 loops' size and conformation, disrupting the native contacts and reducing the interacting hydrophobic surface accessible area, mainly due to the loss of the hydrophobic pocket (Fig. 4C) . Indels around the N3/N5 loops resulted in a significant loss of interactions (both electrostatic and hydrophobic) that can dramatically impact the binding free energy and, therefore, the binding affinity between those NTD deletion variants and the NAb 2-51. Variant N.10 displayed the largest loss of interactions, followed by variants with deletions ∆242-244, ∆141-144, and ∆143-144/∆144 ( Table  2) . Loss of interactions for P.1/P.2 variants was larger than for B.1.1.28/33 variants with the same NTD deletions. The NTD indels ∆69-70, ∆189-190, ∆211, and ins214ANRN did not affect the NTD antigenic supersite (Fig. 4A) . Still, they occur at other loops that comprise putative epitope regions covering residues 64-83, 168/173-188, and 209-216 (Supplementary Appendix Table  A6 ) and lead to conformational changes ( Supplementary Fig.  S2 ), which might affect Ab binding outside the NTD antigenic supersite.

Our study revealed that NTD deletions characteristic of VOCs B.1.1.7 (∆69-70 and ∆144) and B.1.351 (∆242-244) as well as other NTD indels (∆143-144, ∆141-144, [189] [190] and ins214ANRN) occurred at multiple times during the evolution of lineage P.1 and also sporadically in lineages B.1.1.28, B.1.1.33, and P.2 in Brazil and worldwide. Most P.1 variants with similar NTD deletions detected in different countries were not closely related to each other, supporting that they arose independently. We detected a low level of community transmission of P.1+∆144 and P.1 + ins214 variants in the Amazonas state and of a P.1+∆69-70 variant in the Santa Catarina and São Paulo states. We also found evidence of local spread of a P.1+∆141-143 variant in the USA and a P.1+∆139-144 variant in France. Our study also revealed that a new lineage N.10 carrying multiple mutations with phenotypic implications in the RBD (E484K and V445A) and NTD (I210V, ∆211, L212I, ∆141-144, and ∆256-258) of the S protein evolved within lineage B.1.1.33 and constituted an emergent VOI that seems to be mostly restricted to the Northeastern Brazilian state of Maranhão.

The two most frequent NTD indels in lineage P.1 samples were ∆69-70 and ∆144, as observed in the VOC B.1.1.7. We detected the recurrent emergence of deletion ∆69-70 in Brazil (states of Santa Catarina and São Paulo), Aruba, Austria,] Spain, and the USA and of deletion ∆144 in Brazil (states of Amazonas, Bahia, Rio de Janeiro, and São Paulo), Spain, and the USA. While NTD deletions ∆69-70 and ∆144 arose multiple times during the evolution of VOC P.1, the simultaneous presence of both mutations was only detected in one P.1 sequence from Spain. The detection of P.1 genomes with convergent NTD deletions with VOCs B.1.1.7 and B.1.351 in different countries from the Americas (Brazil, Aruba, and the USA) and Europe (Austria, France, and Spain) bring caution about the specificity of published or commercial real-time reverse transcription polymerase chain reaction (PCR) protocols to distinguish different VOCs. Indeed, we alert against using the failure to detect the S gene (due to mutation ∆69-70) by certain We observed that SARS-CoV-2 variants harboring NTD indels have arisen in different lineage backgrounds, and its frequency has increased globally since mid-2020. Recent genomic findings showed a sudden landscape change in SARS-CoV-2 evolution since October 2020, coinciding with the independent emergence of VOCs carrying multiple convergent amino acid replacements at the RBD of the S protein (Martin et al. 2021) . One hypothesis is that such a major selection pressure shift on the virus genome is driven by the increasing worldwide human population immunity acquired from natural SARS-CoV-2 infection that might also select for convergent deletions at NTD. Our findings suggest that P.1, P.2, and N.10 variants with NTD indels here detected might have evolved to escape from NAb against NTD and could be more resistant to neutralization than the parental viruses. Notably, the sequential acquisition of RBD and NTD mutations observed in the VOC P.1 recapitulates the evolution pattern of the VOC B.1.351 that first acquired RBD mutations E484K and N501Y and sometime later the NTD deletion ∆242-244 (Tegally et al. 2021 ). 

Our in silico analyses suggest that several NTD indels detected at RDR2 and RDR4 probably abrogate the binding of NAb directed against the antigenic supersite and thus represent an adaptive mechanism of immune escape. Several studies of SARS-CoV-2 evolution in vitro and ex vivo also support this hypothesis. In vitro co-incubation of SARS-CoV-2 with highly neutralizing plasma from a coronavirus-19 (COVID-19) convalescent patient revealed an incremental resistance to neutralization followed by the stepwise acquisition of indels at N3/N5 loops (Andreano et al. (Truong et al. 2021) . Finally, a recent study revealed the emergence of virus haplotypes bearing NTD deletions ∆144 and ∆141-144 following the development of autologous anti-NTD-specific antibodies during acute infection in one immunocompetent individual (Ko et al. 2021: 1) .

The impact of indels at RDR1 and RDR3 on immune escape remains unknown as they did not affect the NTD antigenic supersite. Our in silico analyses supports that the NTD indels at RDR1 and RDR3 occur at external loops that comprise putative epitope regions and leads to conformational changes that might affect Ab binding outside the NTD antigenic supersite. A recent study found that some Ab from convalescent subjects directed against the NTD induce the open conformation of RBD and enhance the binding capacity of the S protein to ACE2 receptor and infectivity of SARS-CoV-2 (Liu et al. 2021) . Notably, all the infectivity-enhancing Abs recognized a specific site covering residues 64-66, 187, and 213-214 of the NTD. Another study supports that the NTD deletion ∆69-70 is not an antibody evasion mechanism, but it increases the viral infectivity associated with enhanced incorporation of cleaved S into virions (Meng et al. 2021) . Thus, indels around the RDR1 (∆69-70) and RDR3 (∆211 and ins214) might enhance the infectivity of SARS-CoV-2 lineages carrying RBD immune escape mutations.

Analyses of sarbecoviruses in bats and other species identified that the NTD RDRs of the SARS-CoV-2 overlap with four NTD IRs that are prone to gain or lose short nucleotide sequences during sarbecoviruses evolution (Holmes et al. 2021) . Most NTD indels detected in the VOC P.1 and VOIs P.2/N.10 occurred in or adjacent to the sarbecoviruses IR-2 (∆69-70), IR-3 (∆144, ∆141-144), IR-4 (∆211 and ins214), and IR-5 (∆242-244 and ∆256-258). While NTD deletions in the IR-2, IR-3, and IR-5 were already detected in VOCs B. 1.1.7, B.1.351, and B.1.617.2 , the presence of indels in the IR-4 seems to be rare. The three-to four-amino-acid insertion noticed in the sub-clade P.1 + ins214ARNR and in other emergent SARS-CoV-2 lineages resembles the insertions observed in some bat SC2r-CoVs from China (ins214GATP), Thailand (ins214GATP), and Japan (ins214GATS). This not only supports that all IR remains evolutionarily active in SARS-CoV-2 but also demonstrates that insertions at IR, as the one observed at the furin cleavage site, are part of the natural evolutionary process of SARS-CoV-2.

In summary, our findings suggest that the SARS-CoV-2 VOCs and VOIs are continuously adapting and evolving in Brazil through the acquisition of Spike NTD indels. Some variants like P.1+∆69-70, P.1+∆144, P.1 + ins214ANRN, and N.10 might represent newly emergent VOC/VOI, and its community dissemination requires careful monitoring. Our findings also highlight the urgent need to address the SARS-CoV-2 vaccines' efficacy toward emergent SARS-CoV-2 variants carrying RBD and NTD mutations and deletions of concern. Furthermore, the uncontrolled community transmission of SARS-CoV-2 in Brazil and other countries leads to the risk of the emergence of more transmissible variants. The recurrent rise of NTD ins214 variants in different SARS-CoV-2 lineages circulating in the Americas and Europe since November 2020 and its impact on vaccine efficacy also deserve further attention.

Our genomic survey of SARS-CoV-2-positive samples sequenced by the Fiocruz COVID-19 Genomic Surveillance Network between 12 March 2020 and 28 June 2021 identified 21 sequences with mutations of concern in the RBD and indels in the NTD (Supplementary Appendix Table A1 ). The SARS-CoV-2 genomes were recovered using Illumina sequencing protocols as previously described (Nascimento et al. 2020; Resende et al. 2020) . The FASTQ reads obtained were imported into the CLC Genomics Workbench version 20.0.4 (Qiagen A/S, Denmark), trimmed and mapped against the reference sequence EPI_ISL_402124 (hCoV-19/Wuhan/WIV04/2019) available in EpiCoV database in the GISAID (https://www.gisaid.org/). The alignment was refined using the InDels and Structural Variants module. Additionally, the same reads were imported in a different pipeline (Paiva et al. 2020) based on Bowtie2 and bcftools (Li 2011) mapping and consensus generation allowing us to further confirm the indels supported by paired-end reads, removing putative indels with less than 10× of sequencing depth and with mapping read quality score below 10 for all samples sequenced in this study. BAM files were used to generate sequencing coverage plots onto indels using the Karyoploter R package (Gel and Serra 2017) . Sequences were combined with SARS-CoV-2 and SC2r-CoV from bats and pangolins available in the EpiCoV database in GISAID by 1 March 2021 (Supplementary Appendix Table A7 ). This study was approved by the FIOCRUZ-IOC (68118417.6.0000.5248 and CAAE 32333120.4.0000.5190), the Amazonas State University Ethics Committee (CAAE: 25430719.6.0000.5016), and the Brazilian Ministry of the Environment (MMA) A1767C3.

SARS-COV-2 P.1 and N.10 sequences here obtained were aligned with high quality (<1 per cent of N) and complete (>29 kb) lineages P.1, N.10, and B.1.1.33 Brazilian sequences that were available in EpiCoV database in the GISAID (https://www.gisaid.org/) on 31 May 2021. All P.1 sequences sampled worldwide available in the EpiCoV database that harbor the same NTD indels described in Brazilian sequences were also downloaded. Sequences were aligned using Clustal W (Larkin et al. 2007 ) and then subjected to ML phylogenetic analysis using IQ-TREE v2.1.2 (Nguyen et al. 2015) under the general time-reversible model of nucleotide substitution with a gamma-distributed rate variation among sites, four rate categories (G4), a proportion of invariable sites (I) and empirical base frequencies (F) nucleotide substitution model, as selected by the ModelFinder application (Kalyaanamoorthy et al. 2017 ). The branch support was assessed by the approximate likelihood-ratio test based on the Shimodaira-Hasegawa-like procedure with 1,000 replicates. Indels were not treated as informative characters for phylogenetic reconstructions. The S amino acid sequences from selected SARS-CoV-2 and SC2r-CoV lineages available in the Epi-CoV database were also aligned using Clustal W (Larkin et al. 2007) and adjusted by visual inspection.

The EpiCov worldwide metadata package was downloaded from GISAID (https://www.gisaid.org/) on 31 May. Along with several patient metadata, the file included all amino acid substitutions (including indels) relative to hCoV-19/Wuhan/WIV04/2019 genome reference. Entries without complete sampling date and from non-human hosts were excluded. Sequences were then filtered for the presence of insertions or deletions at positions 13-305 of the spike protein. Aiming to show the continuous emergence of NTD indels, lineages B.1.1.7, B.1.351, and B.1.351-derived lineages (sublineages) were excluded from the analysis, since they are known to harbor indels in the NTD and they represent a large amount of the EpiCov database. Due to the reduced number of samples from May in comparison with previous months, the proportion of sequences carrying NTD indels was only plotted up to 30 April. Data cleaning and processing were performed in R and plotted using the ggplot2 package.

The resolved crystallographic structure of SARS-CoV-2 NTD protein bound to the NAb 2-51 was retrieved from the Protein Databank (PDB) under the accession code 7L2C (Cerutti et al. 2021) . Missing residues of the chain A, corresponding to the NTD coordinates, were modeled using the user template mode of the Swiss-Model webserver (https://swissmodel.expasy.org/) (Waterhouse et al. 2018) and was used as starting structure for the NTD wild-type. This structure was then used as a template to model the NTD variants using the Swiss-Model webserver. The modeled structures of the NTDs variants were superimposed onto the coordinates of the PDB ID 7L2C to visualize the differences between the NTD-antibody binding interfaces. Image rendering was carried out using Visual Molecular Dynamics software (Humphrey, Dalke, and Schulten 1996) . The NTDantibody complexes were geometry optimized using a maximum of 5,000 steps or until it reached a convergence value of 0.001 REU (Rosetta energy units) using the limited-memory BroydenFletcher-Goldfarb-Shanno algorithm, complying with the Armijo-Goldstein condition, as implemented in the Rosetta suite of software 3.12 (Leaver-Fay et al. 2011) . Geometry optimization was accomplished through the atomistic Rosetta energy function 2015 (REF15), while preserving backbone torsion angles. Proteinprotein interface analyses were performed using the Protein Interactions Calculator webserver (http://pic.mbu.iisc.ernet.in/) (Tina, Bhadra, and Srinivasan 2007) , the 'Protein interfaces, surfaces and assemblies' service at the European Bioinformatics Institute (https://www.ebi.ac.uk/pdbe/pisa/pistart.html) (Krissinel and Henrick 2007) , and the InterfaceAnalyzer protocol of the Rosetta package interfaced with the RosettaScripts scripting language (Fleishman et al. 2011) . For the interfaceAnalyzer, the maximum solvent accessible surface area (SASA) that is allowed for an atom to be defined as buried is 0.01 Å 2 , with a SASA probe radius of 1.2 Å.

Epitopes in the NTD region were predicted by the ElliPro Antibody Epitope Prediction server (Ponomarenko et al. 2008) . NTDs are shown as predicted linear epitopes when using PDB accession codes 6VXX (Wrapp et al. 2020 ) and 6VSB (Walls et al. 2020) , (structural coordinates corresponding to the entire S protein), along with a minimum score of 0.9, i.e. a highly strict criterion.

Supplementary data is available at Virus Evolution online.

EmergeSaude/AM call 005/2020 and Rede Genômica de Vigilância em

Tecnologia, Inovações e Comunicações/Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq/Ministério da Saúde -MS/ FNDCT/SCTIE/Decit (grants 402457/2020-9

respectively). G.B. is also funded by the Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro-FAPERJ (grant number E-26/202

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

Two-step Strategy for the Identification of SARS-CoV-2 Variant of Concern 202012/01 and Other Variants with Spike Deletion H69-V70, France

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Antibody Cocktail to SARS-CoV-2 Spike Protein Prevents Rapid Mutational Escape Seen with Individual Antibodies

Potent SARS-CoV-2 Neutralizing Antibodies Directed against Spike N-terminal Domain Target a Single Supersite

Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment

A Neutralizing Human Antibody Binds to the Nterminal Domain of the Spike Protein of SARS-CoV-2

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Sensitivity of SARS-CoV-2 B.1.1.7 To mRNA Vaccine-elicited Antibodies

Antibody Evasion by the P.1 Strain of SARS-CoV-2

Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in Manaus: Preliminary Findings -SARS-CoV-2 coronavirus/nCoV-2019 Genomic Epidemiology

Immune Evasion of SARS-CoV-2 Variants of Concern Is Driven by Low Affinity to Neutralizing Antibodies

RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite

Predominance of the SARS-CoV-2 Lineage P.1 And Its Sublineage P.1.2 In Patients from the Metropolitan Region of Porto Alegre, Southern Brazil

Spike Protein Mutations in Novel SARS-CoV-2 'Variants of Concern' Commonly Occur in or near Indels

karyoploteR: An R/Bioconductor Package to Plot Customizable Genomes Displaying Arbitrary Data

Effect of Natural Mutations of SARS-CoV-2 on Spike Structure

Comprehensive Mapping of Mutations in the SARS-CoV-2 Receptor-binding Domain that Affect Recognition by Polyclonal Human Plasma Antibodies

SARS-CoV-2 Variants B.1.351 and B.1.1.248: Escape from Therapeutic Antibodies and Antibodies Induced by Infection and Vaccination

Spike Protein Sequences of Cambodian, Thai and Japanese Bat Sarbecoviruses Provide Insights into the Natural Evolution of the Receptor Binding Domain and S1/S2 Cleavage Site

VMD: Visual Molecular Dynamics

ModelFinder: Fast Model Selection for Accurate Phylogenetic Estimates

SARS-CoV-2 Evolution during Treatment of Chronic Infection

Emergence of Multiple SARS-CoV-2 Mutations in an Immunocompromised Host', medRxiv

High-throughput, Single-copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19

40 Minutes RT-qPCR Assay for Screening Spike N501Y and HV69-70del Mutations

Inference of Macromolecular Assemblies from Crystalline State

Genomic Surveillance of SARS-CoV-2 Tracks Early Interstate Transmission of P.1 Lineage and Diversification within P.2 Clade in Brazil

Clustal W and Clustal X Version 2.0.1'

ROSETTA3: An Object-oriented Software Suite for the Simulation and Design of Macromolecules

A Statistical Framework for SNP Calling, Mutation Discovery, Association Mapping and Population Genetical Parameter Estimation from Sequencing Data

Potent Neutralizing Antibodies against Multiple Epitopes on SARS-CoV-2 Spike

An Infectivity-enhancing Site on the SARS-CoV-2 Spike Protein Targeted by Antibodies

The Emergence and Ongoing Convergent Evolution of the N501Y Lineages Coincides with a Major Global Shift in the SARS-CoV-2 Selective Landscape

Detection of SARS-CoV-2 Lineage P.1 In Patients from a Region with Exponentially Increasing Hospitalisation Rate

N-terminal Domain Antigenic Mapping Reveals a Site of Vulnerability for SARS-CoV-2

Recurrent Deletions in the SARS-CoV-2 Spike Glycoprotein Drive Antibody Escape

Recurrent Emergence of SARS-CoV-2 Spike Deletion H69/V70 and Its Role in the Alpha Variant B.1.1.7

Genomic and Phylogenetic Characterisation of an Imported Case of SARS-CoV-2 in Amazonas State, Brazil', Memórias do Instituto Oswaldo Cruz

COVID-19 in Amazonas, Brazil, was Driven by the Persistence of Endemic Lineages and P.1 Emergence

Molecular Dynamic Simulation Reveals E484K Mutation Enhances Spike RBD-ACE2 Affinity and the Combination of E484K, K417N and N501Y Mutations (501Y.V2 Variant) Induces Conformational Change Greater than N501Y Mutant Alone

IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies

Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

ElliPro: A New Structure-based Tool for the Prediction of Antibody Epitopes

Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike Mutations -SARS-CoV-2 coronavirus/nCoV-2019 Genomic Epidemiology

A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein was Identified within Lineage B.1.1.33 Circulating in Brazil

Early Detection of P.1 Variant of SARS-CoV-2 in a Cluster of Cases in Salvador, Brazil

Molecular Surveillance of the On-going SARS-COV-2 Epidemic in Ribeirao Preto City, Brazil

Emergence of a SARS-CoV-2 Variant of Concern with Mutations in Spike Glycoprotein

PIC: Protein Interactions Calculator

Early Genomic Detection of SARS-CoV-2 P.1 Variant in Northeast Brazil

Persistent SARS-CoV-2 Infection and Increasing Viral Variants in Children and Young Adults with Impaired Humoral Immunity

Genomic Characterization of a Novel SARS-CoV-2 Lineage from Rio De Janeiro, Brazil'

Prevalent, Protective, and Convergent IgG Recognition of SARS-CoV-2 non-RBD Spike Epitopes in COVID-19 Convalescent Plasma

Evidence for SARS-CoV-2 Related Coronaviruses Circulating in Bats and Pangolins in Southeast Asia

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7

Increased Resistance of SARS-CoV-2 Variant P.1 To Antibody Neutralization', bioRxiv

Spike Mutations in SARS-CoV-2 Variants Confer Resistance to Antibody Neutralization

SWISS-MODEL: Homology Modelling of Protein Structures and Complexes

SARS-CoV-2 501Y.V2 Escapes Neutralization by South African COVID-19 Donor Plasma

Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation

The authors wish to thank all the health-care workers and scientists who have worked hard to deal with this pandemic threat, the GISAID team, and all the EpiCoV database's submitters; GISAID acknowledgment table containing sequences used in this study is in Supplementary Appendix Table A8 . We also appreciate the support of the Fiocruz COVID-19 Genomic Surveillance Network (http://www.genomahcov.fiocruz.br/) members, the Respiratory Viruses Genomic Surveillance Network of the General Laboratory Coordination (CGLab), Brazilian Ministry of Health (MoH), Brazilian Central Laboratory States (LACENs), and the Amazonas surveillance teams for the partnership in the viral surveillance in Brazil.

Financial support was provided by FAPEAM (PCTI-